Back to results
US 2010/0144692 A1Published application
Ulipristal Acetate Tablets
AssigneeLaboratoire Hra-Pharma
InventorsErin Gainer, Helene Guillard
Life of this patent
Estimating the term…
Abstract
The invention relates to a pharmaceutical tablet for oral administration comprising ulipristal acetate together with the following excipients: a diluent in an amount of 60 to 95 wt %, a binding agent in an amount of 1 to 10 wt %, croscarmellose sodium in an amount of 1 to 10 wt %, and magnesium stearate in an amount of 0 to 5 wt %.
Claims15
A pharmaceutical tablet for oral administration comprising ulipristal acetate in an amount of 3 to 18 wt %, together with the following excipients:
- a diluent in an amount of 60 to 95 wt %, a binding agent in an amount of 1 to 10 wt %, croscarmellose sodium in an amount of 1 to 10 wt %, and magnesium stearate in an amount of 0 to 5 wt %, wt % designating an amount by weight, as a percentage of the total weight of the composition.
Dependencies are inferred from the claim text.